Publications en collaboration avec des chercheurs de Dana–Farber Cancer Institute (3)

2026

  1. Immune biomarkers of increased infection risk in multiple myeloma

    Blood, Vol. 147, Núm. 18, pp. 2081-2088

  2. Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs

    Blood, Vol. 147, Núm. 10, pp. 1070-1082

2024

  1. Inhibition of MICA and MICB shedding enhances memory-like NK-cell–mediated cytotoxicity against multiple myeloma

    Blood Advances, Vol. 8, Núm. 20, pp. 5365-5370